![Long-acting cabotegravir injections once every eight weeks was better than the daily tablet used for HIV prevention. [CREDIT: Shutterstock]](https://media.premiumtimesng.com/wp-content/files/2020/11/file-20201112-17-ywbtm0-350x250.jpg)
Large Africa study makes important breakthrough in HIV prevention
The findings suggest that cabotegravir is much more effective than Truvada in preventing HIV infection in women.
Tag: Ina Skosana
The findings suggest that cabotegravir is much more effective than Truvada in preventing HIV infection in women.